UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018968 |
|---|---|
| Receipt number | R000021872 |
| Scientific Title | Phase II dose titration study of regorafenib for patients with unresectable metastatic colorectal cancer who are progressed after standard chemotherapy |
| Date of disclosure of the study information | 2015/09/10 |
| Last modified on | 2023/04/10 12:55:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/09/10 16:24:31 | ||
| 2 | Update | 2015/12/10 11:02:46 | Recruitment status |
|
| 3 | Update | 2016/10/18 15:22:12 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2016/10/18 15:23:20 | UMIN ID1 |
|
| 5 | Update | 2018/03/13 10:57:25 | Recruitment status Publication of results |
|
| 6 | Update | 2020/09/14 23:06:34 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Zip code Last name of contact person Last name of contact person Division name Zip code Division name Organization Organization Address Address Tel |
|
| 7 | Update | 2023/04/10 12:55:05 | Recruitment status Date of IRB Last follow-up date |
